NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 668485 | Null | 0.0135714101922724 | 0.24062945 |
NSC 673499 | Null | 0.0135714101922724 | 0.50377897 |
NSC 682996 | Null | 0.0135714101922724 | 0.41178499 |
NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0135714101922724 | 0.30467777 |
NSC 6926 | Null | 0.0135714101922724 | 0.32514415 |
NSC 717468 | Null | 0.0135714101922724 | 0.3219235 |
NSC 718781 | Erlotinib hydrochloride | 0.0135714101922724 | -0.25782136 |
NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0135714101922724 | 0.28716498 |
NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0139796580235792 | 0.40742985 |
NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0139796580235792 | 0.3590368 |